News & Analysis on Clinical Trial Services & Contract Research And Development
Bold is on the hunt for supporters among the industry to help evaluate its investigational anti-cancer therapy as a potential coronavirus treatment, after seeing related elements.
The pharmaceutical company has withdrawn its orphan designation request for its antiviral for the treatment of COVID-19.
The partners will focus on developing five potential exosome treatment for rare diseases.
The US FDA has issued the first emergency use authorization to chloroquine phosphate and hydroxychloroquine sulfate as treatments against coronavirus.
The company has added four mannitols to its Mannogem line, designed for optimal compressibility, binding, disintegration and particle size ranges.
Paid for and content provided by Federal Equipment Company
Companies that want to recover their investment in equipment assets are better positioned if they have a comprehensive plan in place before the surplus is evident